Boule Diagnostics AB 2022 SR
The report highlights Boule's commitment to blood diagnostics and its impact on global health, specifically aligning with UN SDGs 3 and 9. Key focus areas include product safety, environmental impact reduction through optimized transportation, and fostering a values-driven work culture. In 2022, the company achieved a 100% signature rate for its code of conduct among distributors and focused on leadership development. Environmental efforts included using 100% renewable energy for its Swedish facilities and introducing tools to measure carbon footprints.
Company: Boule Diagnostics AB
Sector: Health Care
Country: Sweden
Year: 2022
Type: SR
Pages: 10
Boule Diagnostics AB
The report highlights Boule's commitment to blood diagnostics and its impact on global health, specifically aligning with UN SDGs 3 and 9. Key focus areas include product safety, environmental impact reduction through optimized transportation, and fostering a values-driven work culture. In 2022, the company achieved a 100% signature rate for its code of conduct among distributors and focused on leadership development. Environmental efforts included using 100% renewable energy for its Swedish facilities and introducing tools to measure carbon footprints.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Apr 4, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees